Jonas Brambeck
Senior Investment Director
Joined: 1998
Involved in: Gesynta, Oncopeptides, MinervaX
Interests: Diagnostics, MedTech, Therapeutics, Life Science, Pharma
Jonas focuses on Life Science and since joining Industrifonden in 1998 he has lead a number of investments in pharma and diagnostics.
He has an extensive experience in financing, divestments and public offerings in Life Science companies as well as a significant board experience.
Jonas holds a PhD in Organic chemistry from the Royal Institute of Technology, Stockholm.